Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Setubal – page 52

664 clinical trials in Setubal, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Setubal at a glance
664
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

664 trials in Setubal

Open in trial search

Monkeypox

Not recruiting

Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tecovirimat
  • Sponsor:University Of Oxford

IgA nephropathy

Not recruiting

Study on Sibeprenlimab for Patients with IgA Nephropathy

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Sibeprenlimab
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:AZD4831
  • Sponsor:AstraZeneca AB

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Hereditary ataxia

Not recruiting

Study on Trehalose Dihydrate for Treating Spinocerebellar Ataxia in Adults

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Trehalose Dihydrate (Ph.eur.)
  • Sponsor:Seelos Therapeutics Inc.

Monkeypox

Not recruiting

Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Tecovirimat
  • Sponsor:Universitair Medisch Centrum Utrecht

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm

Not recruiting

Study of Pembrolizumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension

Registered drug
Countries:PortugalPortugal
  • Participants:0–17 years
  • Substances:Bosentan
  • Sponsor:Actelion Pharmaceuticals Ltd.

Oesophageal carcinoma

Not recruiting

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Merck Sharp & Dohme LLC

Hypertonic bladder

Not recruiting

Study on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:IncobotulinumtoxinA
  • Sponsor:Vensica Medical Ltd.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Setubal

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on cardiovascular disease prevention and treatment, including innovative approaches to reduce major cardiovascular events and stroke prevention in patients with atrial fibrillation.

  • Lipoprotein management studies
  • Stroke prevention therapies
  • Atherosclerotic disease prevention

Research aims to evaluate new therapeutic options for reducing cardiovascular risks and improving patient outcomes.

02 Neurological Disorders

Clinical investigations targeting migraine management, including specialized studies for menstrual migraine prevention and acute treatment approaches.

  • Preventive migraine treatments
  • Acute migraine interventions
  • Gender-specific migraine studies

These trials explore innovative therapeutic solutions for various types of migraines.

03 Oncology Research

Advanced studies in breast cancer and non-small cell lung cancer treatments, focusing on targeted therapies and innovative treatment combinations.

  • Hormone receptor-positive breast cancer
  • Metastatic cancer treatments
  • Immunotherapy combinations

Research focuses on developing more effective treatments for various cancer types.

04 Autoimmune Conditions

Comprehensive research into systemic lupus erythematosus and related conditions, including specialized studies for lupus nephritis.

  • Lupus treatments
  • Kidney disease management
  • Chronic urticaria studies

Trials aim to improve treatment options for patients with autoimmune disorders.

05 Metabolic Disorders

Innovative research on type 2 diabetes complications, particularly focusing on diabetic retinopathy and its progression.

  • Diabetic eye disease
  • Glycemic control studies
  • Long-term disease management

Studies evaluate new approaches to managing diabetes-related complications.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.